Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 12.5% during mid-day trading on Tuesday. The company traded as high as C$0.14 and last traded at C$0.14. 175,000 shares traded hands during trading, an increase of 42% from the average daily volume of 122,825 shares. The stock had previously closed at C$0.12.
Voyageur Pharmaceuticals Stock Performance
The stock has a market capitalization of C$30.56 million, a PE ratio of -6.75 and a beta of 0.88. The business has a 50 day moving average price of C$0.15 and a 200 day moving average price of C$0.13. The company has a debt-to-equity ratio of 9.80, a current ratio of 0.23 and a quick ratio of 0.84.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
